Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions
- PMID: 39528070
- DOI: 10.1016/j.arr.2024.102577
Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions
Abstract
Neurodegenerative diseases, as common diseases in the elderly, tend to become younger due to environmental changes, social development and other factors. They are mainly characterized by progressive loss or dysfunction of neurons in the central or peripheral nervous system, and common diseases include Parkinson's disease, Alzheimer's disease, Huntington's disease and so on. Mitochondria are important organelles for adenosine triphosphate (ATP) production in the brain. In recent years, a large amount of evidence has shown that mitochondrial dysfunction plays a direct role in neurodegenerative diseases, which is expected to provide new ideas for the treatment of related diseases. This review will summarize the main mechanisms of mitochondrial dysfunction in neurodegenerative diseases, as well as collating recent advances in the study of mitochondrial disorders and new therapies.
Keywords: Mitochondrial dynamics; Mitochondrial dysfunction; Mitophagy; Neurodegenerative diseases; Oxidative stress.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases.Rev Neurosci. 2024 Aug 20;36(1):53-90. doi: 10.1515/revneuro-2024-0080. Print 2025 Jan 29. Rev Neurosci. 2024. PMID: 39174305 Review.
-
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.J Neurol Sci. 2007 Jun 15;257(1-2):221-39. doi: 10.1016/j.jns.2007.01.033. Epub 2007 Apr 25. J Neurol Sci. 2007. PMID: 17462670 Review.
-
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.Mitochondrion. 2023 Jul;71:83-92. doi: 10.1016/j.mito.2023.05.007. Epub 2023 Jun 1. Mitochondrion. 2023. PMID: 37269968 Review.
-
Mitochondrial biogenesis: pharmacological approaches.Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118. Curr Pharm Des. 2014. PMID: 24606795
-
Mitochondrial dysfunction in neurodegenerative disorders.Neurotherapeutics. 2024 Jan;21(1):e00292. doi: 10.1016/j.neurot.2023.10.002. Epub 2023 Dec 19. Neurotherapeutics. 2024. PMID: 38241161 Free PMC article. Review.
Cited by
-
Neuroglobin: A promising candidate to treat neurological diseases.Neural Regen Res. 2026 Apr 1;21(4):1292-1303. doi: 10.4103/NRR.NRR-D-24-01503. Epub 2025 Jun 19. Neural Regen Res. 2026. PMID: 40536996 Free PMC article.
-
Unraveling the Vicious Cycle: Oxidative Stress and Neurotoxicity in Neurodegenerative Diseases.FASEB Bioadv. 2025 Sep 3;7(8):e70041. doi: 10.1096/fba.2025-00093. eCollection 2025 Aug. FASEB Bioadv. 2025. PMID: 40909873 Free PMC article. Review.
-
Causes of and Solutions to Mitochondrial Disorders: A Literature Review.Int J Mol Sci. 2025 Jul 11;26(14):6645. doi: 10.3390/ijms26146645. Int J Mol Sci. 2025. PMID: 40724895 Free PMC article. Review.
-
Inherent potential of mitochondria-targeted interventions for chronic neurodegenerative diseases.Neural Regen Res. 2026 Apr 1;21(4):1409-1427. doi: 10.4103/NRR.NRR-D-24-01507. Epub 2025 Apr 29. Neural Regen Res. 2026. PMID: 40313114 Free PMC article.
-
The Role of N6-Methyladenosine in Mitochondrial Dysfunction and Pathology.Int J Mol Sci. 2025 Apr 11;26(8):3624. doi: 10.3390/ijms26083624. Int J Mol Sci. 2025. PMID: 40332101 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical